Biktarvy Archives -

A patent dispute between ViiV Healthcare and Gilead Sciences has been resolved, with Gilead agreeing to pay a

ViiV claims $1.25bn settlement from Gilead in HIV patent dispute

https://pharmaphorum.com/news/viiv-claims-1-25bn-settlement-from-gilead-in-hiv-patent-dispute/

US pharma giant Gilead Sciences has accused a network of unauthorised suppliers and distributors of selling more than

Gilead takes legal action against counterfeit HIV drug network

https://pharmaphorum.com/news/gilead-takes-legal-action-against-counterfeit-hiv-drug-network/

Gilead has become the latest pharma company to raise its full year sales forecasts following stronger than expected

Gilead ups forecasts as new HIV drug boosts sales

https://pharmaphorum.com/news/gilead-ups-sales-forecasts-as-new-hiv-drug-boosts-sales/

Biktarvy